VALERIO THERAPEUTICS

Analyst Reco. Valerio Therapeutics Börse Stuttgart

Equities

C4X

FR0010095596

Delayed Börse Stuttgart Other stock markets 02:00:50 12/06/2024 pm IST			5-day change	1st Jan Change
0.097 ^EUR	-0.41%		-0.20%	-35.92%

22/05	Valerio Therapeutics S.A. Provides Clinical Development Update on Its Phase 1/2 VIO-01 Clinical Trial	CI
30/04	Valerio Therapeutics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Onxeo : Bryan Garnier & Co initiates the coverage of Onxeo with a “Buy” recommendation	29/20/29	PU
Bryan Garnier & Co Initiates Coverage of Onxeo with a “Buy” Recommendation	27/20/27	GL
Onxeo : Bryan Garnier & Co Initiates the Coverage of Onxeo with a “Buy” Recommendation	27/20/27	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer